KO
44
3
MAS
78
2
PH
59
3
BDX
54
2
JCI
49
-5
LOW
55
2
REGN
46
-2
ACN
47
4
FSLR
66
-4
STI
5
-2
SBUX
35
-4
WDC
66
-3
ORCL
55
-10
ALLE
69
5
FOXA
60
-2
JPM
62
-2
BLK
67
-2
SO
55
5
RIG
32
-5
ILMN
45
3
KO
44
3
MAS
78
2
PH
59
3
BDX
54
2
JCI
49
-5
LOW
55
2
REGN
46
-2
ACN
47
4
FSLR
66
-4
STI
5
-2
SBUX
35
-4
WDC
66
-3
ORCL
55
-10
ALLE
69
5
FOXA
60
-2
JPM
62
-2
BLK
67
-2
SO
55
5
RIG
32
-5
ILMN
45
3
Financhill
Back

Palantir Technologies- Ordinary Shares - Class A Vs. Halozyme Therapeutics Inc. Industry Stock Comparison

Sell
43

PLTR
Palantir Technologies- Ordinary Shares - Class A

Last Price:
$143.31
Seasonality Move:
27.31%
Buy
89

HALO
Halozyme Therapeutics Inc.

Last Price:
$70.40
Seasonality Move:
7.14%
Sell
43
Palantir Technologies- Ordinary Shares - Class A (PLTR) is a Sell

Is Palantir Technologies- Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Palantir Technologies- Ordinary Shares - Class A [PLTR] share price is $157.75. The Score for PLTR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PLTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
89
Halozyme Therapeutics Inc. (HALO) is a Buy

Is Halozyme Therapeutics Inc. a Buy, Sell or Hold?

  • The current Halozyme Therapeutics Inc. [HALO] share price is $69.98. The Score for HALO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

PLTR Stock Price Chart

What is Palantir Technologies- Ordinary Shares - Class A's stock price today?

HALO Stock Price Chart

What is Halozyme Therapeutics Inc.'s stock price today?

  • The Halozyme Therapeutics Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.

PLTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 39.24 Buy
Relative Strength Index (14 RSI): 43.78 Sell
Chaikin Money Flow: -122697486 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (152.57 - 178.59) Sell
Bollinger Bands (100): (103.22 - 158.24) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.49 Buy
Relative Strength Index (14 RSI): 84.42 Buy
Chaikin Money Flow: 473951 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.38 - 64.94) Buy
Bollinger Bands (100): (53.41 - 62.71) Buy

PLTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 178.87 Sell
20-day SMA: 169.01 Sell
50-day SMA: 152.18 Buy
200-day SMA: 104.25 Buy
8-day EMA: 170.65 Sell
20-day EMA: 139 Buy
50-day EMA: 81.86 Buy
200-day EMA: 25.49 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.84 Buy
20-day SMA: 62.17 Buy
50-day SMA: 57.7 Buy
200-day SMA: 56.22 Buy
8-day EMA: 65.29 Buy
20-day EMA: 51.59 Buy
50-day EMA: 30.13 Buy
200-day EMA: 9.36 Buy

Palantir Technologies- Ordinary Shares - Class A Earnings Growth & PLTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.05 per share, an increase this year of $0.27 per share, and an increase next year of $0.20 per share.

Halozyme Therapeutics Inc. Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, an increase next quarter of $0.32 per share, an increase this year of $1.92 per share, and an increase next year of $1.80 per share.

Palantir Technologies- Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):